An interventional study of Dialectical Behaviour Therapy adapted for adolescents (DBT-A) and Dialectical Behaviour Therapy - Standard version (DBT) in Self Harm and Borderline Personality Disorder, sponsored by Oslo University Hospital. Recruiting at 5 sites in Norway. Open to participants aged 12 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Self-Injurious Behavior with a site in Norway — 5 open to participants now, 5 under way, none of them phase 3. Self-Injurious Behavior · Norway.
Among the 11 studies in Self-Injurious Behavior with a site in Norway, this one is the only one that started in 2018, is one of 8 with no phase, and was the 7th registered.
303 studies on the registry are indexed under Self-Injurious Behavior; 105 are open to participants now.
Browse Self-Injurious Behavior studies →5 of the 11 studies in Self-Injurious Behavior with a site in Norway are open now. Recruiting first, the newest first:
Haukeland University Hospital · Sites in Norway
Ages 13–18
Norwegian University of Science and Technology · Sites in Norway
Ages 18+
Haukeland University Hospital · Sites in Norway
Ages 18–65 · Healthy volunteers
Haukeland University Hospital · Sites in Norway
Ages 14–17
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 69 Self-Injurious Behavior studies recruiting now, 16 (23%) set no upper age limit and 51 (74%) stop at 75 or younger; 46 take children under 18; 12 take healthy volunteers.
This study: 12 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2018.
This study's planned enrollment of 250 is above the median of 70 across 254 interventional studies indexed under Self-Injurious Behavior.
Median enrollment 77 across the 9 interventional studies, 1,020 across the 2 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 4 most frequent:
Oslo University Hospital is the lead sponsor of 835 studies on the registry; 148 are open to participants now.
Oslo University Hospital has 6 studies filed under Self-Injurious Behavior — fewer than ten, so there is no comparison to draw.
1 of the studies in Self-Injurious Behavior with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07450105Haukeland University HospitalIntensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 11 studies in Self-Injurious Behavior with a site in Norway, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in a uniform and systematic way that will enable comparison across clinical settings and programmes. The collected data constitute the basis for conducting the clinical study with the overall aim to study predictors of the clinical course and treatment response in patients admitted to DBT programmes in Norway.
The aim of the project is to collect data from systematic and uniform clinical assessments to study predictors of the clinical course and treatment response in patients admitted to and treated in clinical units delivering Dialectical Behaviour Therapy in Norway.
Aims and research questions:
The study will address the following main research questions:
Methods:
A uniform protocol for psychiatric diagnostics and clinical assessment of patients who receive treatment at the participating clinical units will be used. Since some participating clinical units will treat adult patients and some will treat children and adolescents, the protocol will offer assessment instrument suitable for the specific age group whenever this is relevant. The evaluation system includes assessments at baseline before treatment starts, evaluation at several time points during the treatment period, at termination of treatment and at follow-up. Assessments will be made both through interviews and ratings made by therapists and through self-report from patients.
Self-reports will be filled out electronically by patients, on tablets stationed at each participating clinical unit. At intervals patients will also provide self-rated information on dimensions such as emotions, cognitions and impulsive behaviour several times per day through a mobile app developed specifically for the purpose, so-called Ecological Momentary Assessment (EMA). Interview data and ratings will be entered into the database by each clinician to tablets in a similar fashion as self-report data from patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dialectical Behavior Therapy, delivered for 20 weeks for adolescents (DBT-A) or 52 weeks for adults (standard DBT.
Behavioral: Dialectical Behaviour Therapy adapted for adolescents (DBT-A) · Behavioral: Dialectical Behaviour Therapy - Standard version (DBT)
DBT developed by Marsha Linehan (Linehan 1993a; 1993b) and adapted for adolescents (DBT-A) by Miller, Rathus \& Linehan, 2007 consisting of 20 weeks of weekly individual therapy (60 minutes), multifamily skills training (120 minutes), family therapy sessions as needed and telephone coaching outside therapy sessions.
DBT developed by Marsha Linehan (Linehan 1993a, 1993 b) consisting of 1 weekly session of individual therapy (60 minutes), 1 weekly session of skills training (120 minutes), and telephone coaching with individual therapists outside therapy sessions as needed.
Self-harm behaviour
Number of self-harm episodes (split on suicide attempts and non-suicidal self-harm)
Time frame: 4 weeks
Suicidal Ideation (adolescents)
Suicidal Ideation Questionnaire (SIQ-Jr). Min=0, Max=90. Higher scores indicate worse outcome
Time frame: 2 weeks
Depressive symptoms
MADRS (Montgomery Asberg Depression Rating Scale).Min=0, Max=60. Higher scores indicate worse outcome
Time frame: 1 week
Suicidal Ideation (adults)
Beck Scale for Suicidal Ideation (BSS). MIn=0, Max=38. Higher scores indicate worse outcome
Time frame: 4 weeks
Depressive symptoms (adolescents)
Moods and Feelings Questionnaire (MFQ). Min=0, Max=26. Higher scores indicate worse outcome
Time frame: 1 week
Depressive symptoms (adults)
Beck Depression Inventory (BDI). Min=0, Max=63. Higher scores indicate worse outcome
Time frame: 1 week
Borderline Symptoms
Borderline Symptom List (BSL-23). Min=0, Max=92. Higher scores indicate more symptoms.
Time frame: 1 week
Hopelessness
Beck Hopelessness Scale (BHS). Min=0, Max=20. Higher scores indicate more hopelessness.
Time frame: 1 week
Plan to share: No
Started Jan 2018 (actual). Primary completion is estimated for Dec 2029, 143 months after the start.
Of 162 non-industry interventional studies with no phase under Self-Injurious Behavior, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 53. This study's planned 143 months is above that.
Counting every sponsor, half of 164 studies reached it within 28 months; a quarter within 15 and three quarters within 52.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Dec 2025 → Dec 2029 and completion Dec 2025 → Dec 2029.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.